X4 Pharmaceuticals Statistics
Total Valuation
XFOR has a market cap or net worth of $38.50 million. The enterprise value is $17.08 million.
Important Dates
The last earnings date was Tuesday, March 25, 2025, before market open.
Earnings Date | Mar 25, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
XFOR has 173.66 million shares outstanding. The number of shares has increased by 13.08% in one year.
Current Share Class | 173.66M |
Shares Outstanding | 173.66M |
Shares Change (YoY) | +13.08% |
Shares Change (QoQ) | +1.03% |
Owned by Insiders (%) | 5.81% |
Owned by Institutions (%) | 40.30% |
Float | 131.67M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 18.59 |
Forward PS | 3.33 |
PB Ratio | 1.82 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 6.68 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.41, with a Debt / Equity ratio of 3.53.
Current Ratio | 3.41 |
Quick Ratio | 3.16 |
Debt / Equity | 3.53 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -16.13 |
Financial Efficiency
Return on equity (ROE) is -102.26% and return on invested capital (ROIC) is -84.32%.
Return on Equity (ROE) | -102.26% |
Return on Assets (ROA) | -60.18% |
Return on Invested Capital (ROIC) | -84.32% |
Return on Capital Employed (ROCE) | -124.51% |
Revenue Per Employee | $17,881 |
Profits Per Employee | -$261,888 |
Employee Count | 143 |
Asset Turnover | 0.02 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, XFOR has paid $310,000 in taxes.
Income Tax | 310,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.01% in the last 52 weeks. The beta is 0.39, so XFOR's price volatility has been lower than the market average.
Beta (5Y) | 0.39 |
52-Week Price Change | -84.01% |
50-Day Moving Average | 0.42 |
200-Day Moving Average | 0.58 |
Relative Strength Index (RSI) | 27.88 |
Average Volume (20 Days) | 1,683,092 |
Short Selling Information
The latest short interest is 8.64 million, so 4.98% of the outstanding shares have been sold short.
Short Interest | 8.64M |
Short Previous Month | 9.48M |
Short % of Shares Out | 4.98% |
Short % of Float | 6.56% |
Short Ratio (days to cover) | 6.19 |
Income Statement
In the last 12 months, XFOR had revenue of $2.56 million and -$37.45 million in losses. Loss per share was -$0.19.
Revenue | 2.56M |
Gross Profit | 1.76M |
Operating Income | -141.40M |
Pretax Income | 17.73M |
Net Income | -37.45M |
EBITDA | -140.61M |
EBIT | -141.40M |
Loss Per Share | -$0.19 |
Full Income Statement Balance Sheet
The company has $102.06 million in cash and $78.09 million in debt, giving a net cash position of $23.97 million or $0.14 per share.
Cash & Cash Equivalents | 102.06M |
Total Debt | 78.09M |
Net Cash | 23.97M |
Net Cash Per Share | $0.14 |
Equity (Book Value) | 22.15M |
Book Value Per Share | 0.13 |
Working Capital | 79.30M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$130.90 million and capital expenditures -$326,000, giving a free cash flow of -$131.23 million.
Operating Cash Flow | -130.90M |
Capital Expenditures | -326,000 |
Free Cash Flow | -131.23M |
FCF Per Share | -$0.76 |
Full Cash Flow Statement Margins
Gross Margin | 68.83% |
Operating Margin | -5,529.96% |
Pretax Margin | -1,452.48% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
XFOR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -13.08% |
Shareholder Yield | -13.08% |
Earnings Yield | -91.22% |
FCF Yield | -319.65% |
Analyst Forecast
The average price target for XFOR is $2.83, which is 1,176.50% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $2.83 |
Price Target Difference | 1,176.50% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | 158.81% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
XFOR has an Altman Z-Score of -6.79. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -6.79 |
Piotroski F-Score | n/a |